Quick Answer
Onconetix, Inc. reported Stockholders Equity of $15.76 million for fiscal year 2025.
Onconetix, Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $15.76M | +84.5% |
| 2024 | $8.54M | +252.5% |
| 2023 | -$5.60M | -125.0% |
| 2022 | $22.39M | +1447.7% |
| 2021 | $1.45M | -69.4% |
| 2020 | $4.73M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $3.37M | -90.1% | -42.9% |
| June 30, 2025 | $5.91M | +116.5% | +48.0% |
| March 31, 2025 | $3.99M | +118.5% | -53.3% |
| December 31, 2024 | $8.54M | +252.5% | -74.8% |
| September 30, 2024 | $33.91M | +231.3% | +194.7% |
| June 30, 2024 | -$35.81M | -373.9% | -66.3% |
| March 31, 2024 | -$21.53M | -209.3% | -284.4% |
| December 31, 2023 | -$5.60M | -125.0% | -154.7% |
- Onconetix, Inc. showed an increase of +84.5% in Stockholders Equity compared to the prior fiscal year.
- Over the 2020–2025 period, Onconetix, Inc.’s stockholders equity has grown by 233.0% (from $4.73 million to $15.76 million).
- The most recent figure is from Onconetix, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 13, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: